Neuraly
Updated: August 02, 2026
CEO - Seulki Lee
Country: USA | Funding: $36M (+)
Founded: 2016
Website: http://www.neuralymed.com/
Neuraly is a Johns Hopkins School of Medicine spinoff biotech company and aims to introduce the first, disease-modifying agent for neurodegenerative disorders and aging.
Founded: 2016
Website: http://www.neuralymed.com/
Neuraly is a Johns Hopkins School of Medicine spinoff biotech company and aims to introduce the first, disease-modifying agent for neurodegenerative disorders and aging.
